Gsk (GSK) Short term Debt (2015 - 2026)
Gsk (GSK) posted quarterly Short term Debt of -$7.3 billion for Q2 2026, little changed year-over-year from -$7.2 billion in Q2 2025, and down 1.91% quarter-over-quarter from -$7.1 billion in Q1 2026.
Gsk (GSK) Short term Debt (2015 - 2026) Analysis & Trends
Gsk's Short term Debt history runs 12 years deep, the most recent figure standing at -$7.3 billion for Q2 2026.
- In Q2 2026, Short term Debt changed 0.11% year-over-year to -$7.3 billion; the TTM figure through Jun 2026 stood at -$7.3 billion (changed 0.11% YoY), while the FY2025 annual figure was -$7.1 billion, down 341.5% from the prior year.
- Short term Debt for Q2 2026 stood at -$7.3 billion, down from -$7.1 billion in the prior quarter.
- The five-year high for Short term Debt was $3.5 billion in Q4 2023, with the low at -$7.8 billion in Q3 2024.
- The 5-year median for Short term Debt is -$7.1 billion (2026), against an average of -$5.3 billion.
- The sharpest annual moves came in 2023 and 2025: Short term Debt surged 130.92% in 2023, then tumbled 342.64% in 2025.
- Gsk's Short term Debt stood at $1.5 billion in 2022, then soared by 130.92% to $3.5 billion in 2023, then decreased by 15.45% to $3.0 billion in 2024, then sank by 342.64% to -$7.2 billion in 2025, then slipped by 1.24% to -$7.3 billion in 2026.
- Business Quant data shows GSK's Short term Debt at -$7.3 billion in Q2 2026, -$7.1 billion in Q1 2026, and -$7.2 billion in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn |
| 10 | Sanofi | 55.07 Bn | 47.69 Bn | 10.79 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -7.25 Bn |
| Mar 31, 2026 | -7.12 Bn |
| Dec 31, 2025 | -7.16 Bn |
| Sep 30, 2025 | -7.48 Bn |
| Jun 30, 2025 | -7.26 Bn |
| Mar 31, 2025 | -7.37 Bn |
| Dec 31, 2024 | 2.95 Bn |
| Sep 30, 2024 | -7.82 Bn |
| Jun 30, 2024 | -7.63 Bn |
| Mar 31, 2024 | -7.59 Bn |
| Dec 31, 2023 | 3.49 Bn |
| Sep 30, 2023 | -6.95 Bn |
| Jun 30, 2023 | -6.61 Bn |
| Mar 31, 2023 | -6.83 Bn |
| Dec 31, 2022 | 1.51 Bn |
| Sep 30, 2022 | -7.50 Bn |
| Jun 30, 2022 | -6.89 Bn |
| Mar 31, 2022 | -1.96 Bn |
| Dec 31, 2021 | 4.85 Bn |
| Sep 30, 2021 | -6.96 Bn |